The US and New Zealand are the only two countries that allow pharmaceutical companies to directly advertise to patients on TV.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
With no immediate end in sight, analysts are weighing multiple possibilities that could affect prices down the line.
The deal is the Trump administration’s attempt to stake out a new path for balancing national security and the influx of foreign capital.
For key US eVTOL players Joby Aviation and Archer Aviation, the Paris Air Show comes at a critical moment.
NASA is looking to decrease its dependency on key contractor SpaceX, but Jeff Bezos’s Blue Origin is going nowhere at exactly the wrong time.
Elon Musk is again sleeping at Tesla’s offices again, but that may not be enough to restart the top US EV-maker’s engine.
The Switch 2 sold 3.5 million units in its first four days, and Nintendo’s targeting 15 million units for this fiscal year.
In an interview with the Financial Times, Starbucks CEO Brian Niccol said the company is exploring a partial sale of its China business.
Could GLP-1 weight loss drugs like Ozempic and changing economic winds really take a bite out of the almighty Big Mac?
Like the rest of its pre-streaming Hollywood peers, Warner Bros. Discovery finds itself trapped between two eras.
Scale for scale’s sake appears to have become passé, with conglomerates jockeying for market share with a more focused brand identity.
Cyber-criminals often see healthcare firms’ shoddy protection as a “pot of gold.”
An increasing share of NBA endorsement deals has been spread among shoe firms fighting for a piece of Nike’s market share.
As China tightens its grip on rare earths exports, one of its most crucial bargaining chips, the global supply chain is showing cracks.
Snacks now make up around half of the historic soup company’s sales, up from less than a third a decade ago.
At the heart of the biotech deal is a relatively new drug technology called PD-1/VEGF bispecific antibodies.